高级检索
当前位置: 首页 > 详情页

On-Site Visualization Assay for Tumor-Associated miRNAs: Using Ru@TiO2 as a Peroxidase-like Nanozyme

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 自然指数

机构: [1]Department of Laboratory Medicine & Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. [2]Precision Medicine Translational Research Center, West China Hospital, Sichuan University, Chengdu 610213, Sichuan, China. [3]Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. [4]Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, China. [5]College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan 250014, Shandong, China.
出处:
ISSN:

摘要:
Accurate diagnosis of highly aggressive and deadly tumors is essential for effective treatment and improved patient outcomes, and microRNAs (miRNAs) have emerged as crucial biomarkers for their roles in tumor initiation, progression, and metastasis. Herein, we present an on-site visualization colorimetric assay for tumor-associated miRNAs using ruthenium nanoparticle decorated titanium dioxide nanoribbon (Ru@TiO2) as a peroxidase-like (POD) nanozyme. Remarkably, the Ru@TiO2 nanozyme can catalyze the oxidation of chromogenic substrates through its POD-like activity, which is effectively inhibited by pyrophosphate generated during the rolling circle amplification process, thereby enabling miRNA detection through a visible colorimetric readout. This approach provides a highly sensitive and specificity assay for miRNAs in diluted human serum with a detection limit of 100 pM. It shows great potential for clinical diagnostics and biological research, offering a promising tool for early cancer diagnosis and molecular diagnostics.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 化学
小类 | 1 区 分析化学
最新[2023]版:
大类 | 1 区 化学
小类 | 1 区 分析化学
第一作者:
第一作者机构: [1]Department of Laboratory Medicine & Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. [2]Precision Medicine Translational Research Center, West China Hospital, Sichuan University, Chengdu 610213, Sichuan, China.
通讯作者:
通讯机构: [1]Department of Laboratory Medicine & Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. [2]Precision Medicine Translational Research Center, West China Hospital, Sichuan University, Chengdu 610213, Sichuan, China. [3]Center for High Altitude Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. [4]Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, China. [5]College of Chemistry, Chemical Engineering and Materials Science, Shandong Normal University, Jinan 250014, Shandong, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46861 今日访问量:0 总访问量:3333 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号